Colgate-Palmolive (CL) Stock Forecast & Price Target

$89.40 +0.01 (+0.01%)

Closing price 06/12/2026 03:59 PM Eastern

Extended Trading

$89.30 -0.09 (-0.11%)

As of 06/12/2026 07:02 PM Eastern

Compare

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
0

Hold
7

Buy
12

Based on 19 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 7 have given a hold rating, and 12 have given a buy rating for CL.

Consensus Price Target

$95.88
7.25% Upside

According to the 19 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $95.88. The highest price target for CL is $105.00, while the lowest price target for CL is $80.00. The average price target represents a forecasted upside of 7.25% from the current price of $89.40.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CL Analyst Ratings Over Time

Type	Current Forecast 6/13/25 to 6/13/26	1 Month Ago 5/14/25 to 5/14/26	3 Months Ago 3/15/25 to 3/15/26	1 Year Ago 6/13/24 to 6/13/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	12 Buy rating(s)	11 Buy rating(s)	10 Buy rating(s)
Hold	7 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	8 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$95.88	$95.88	$94.75	$102.12
Forecasted Upside	7.25% Upside	7.92% Upside	6.65% Upside	13.21% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	Broader Market
Consensus Rating Score	2.63	2.09	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	7.25% Upside	106.18% Upside	13.95% Upside
News Sentiment Rating	Positive News See Recent CL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
6/11/2026	Sanford C. Bernstein 4 of 5 stars	Cristian Rios Not Rated	Initiated Coverage	Market Perform	$96.00	+7.29%
5/5/2026	Barclays 3 of 5 stars	Lauren Lieberman 2 of 5 stars	Boost Target	Equal Weight	$79.00 ➝ $80.00	-5.98%
5/4/2026	Weiss Ratings 5 of 5 stars		Upgrade	Hold (C) ➝ Hold (C+)
5/4/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$98.00 ➝ $100.00	+16.68%
5/4/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Powers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$99.00	+15.44%
5/4/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
5/4/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$95.00 ➝ $96.00	+12.57%
5/4/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$102.00	+18.87%
5/1/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
4/21/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Neutral ➝ Buy	$93.00 ➝ $100.00	+19.78%
Read this warning immediately (Ad) Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. Read Porter Stansberry's full breakdown and protect your wealth now
4/10/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Spillane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$105.00 ➝ $102.00	+18.58%
4/8/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$100.00 ➝ $92.00	+8.04%
4/8/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lavery Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$96.00 ➝ $92.00	+8.23%
3/31/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold	$85.00	-0.69%
2/2/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$95.00 ➝ $105.00	+16.30%
2/2/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kaumil Gajrawala Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$85.00 ➝ $91.00	-0.79%
2/2/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Ottenstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$94.00 ➝ $100.00	+10.76%
12/11/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor Conrad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
10/20/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Olivia Tong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$105.00 ➝ $95.00	+20.01%
2/3/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Astrachan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$95.00 ➝ $93.00	+7.86%
7/26/2024	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
6/24/2024	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Grundy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$109.00	+12.06%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:28 PM ET.

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, June 9, 2026. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

The current stock price is around $86, reflecting a stable position in the market.
Colgate-Palmolive recently reported earnings that exceeded expectations, indicating strong financial performance and growth potential.
The company has a history of increasing dividends, with a recent quarterly dividend increase to $0.53, showcasing its commitment to returning value to shareholders.
Colgate-Palmolive has a robust market capitalization of approximately $70.76 billion, which suggests a strong presence in the consumer goods sector.
Analysts have given positive ratings and raised price targets for the stock, indicating confidence in its future performance.

Colgate-Palmolive
Bear Case

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

The company has a high debt-to-equity ratio of 16.33, which may indicate potential financial risk if not managed properly.
Despite recent earnings growth, the company's P/E ratio of 34.32 suggests that the stock may be overvalued compared to its earnings.
Colgate-Palmolive's quick ratio of 0.67 indicates that it may struggle to meet short-term liabilities, which could be a concern for liquidity.
The stock has shown relatively low volatility with a beta of 0.31, which may limit potential high returns for investors seeking aggressive growth.
Recent institutional selling, such as Swiss Life Asset Management reducing its holdings by 26%, could signal a lack of confidence among some investors.

CL Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $95.88, with a high forecast of $105.00 and a low forecast of $80.00.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There are currently 7 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CL shares.

According to analysts, Colgate-Palmolive's stock has a predicted upside of 7.25% based on their 12-month stock forecasts.

Over the previous 90 days, Colgate-Palmolive's stock had 4 upgrades by analysts.

Colgate-Palmolive has been rated by research analysts at Bank of America, Barclays, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Rothschild & Co Redburn, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

This page (NYSE:CL) was last updated on 6/13/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CL Analyst Ratings Over Time

CL Analyst Recommendations By Month

CL Price Targets by Month

Colgate-Palmolive Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

Colgate-Palmolive
Bull Case

Colgate-Palmolive
Bear Case

CL Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CL Analyst Ratings Over Time

CL Analyst Recommendations By Month

CL Price Targets by Month

Colgate-Palmolive Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

Colgate-Palmolive Bull Case

Colgate-Palmolive Bear Case

CL Forecast - Frequently Asked Questions

What is Colgate-Palmolive's forecast for 2026?

Should I buy or sell Colgate-Palmolive stock right now?

Does Colgate-Palmolive's stock price have much upside?

Has Colgate-Palmolive been upgraded by Wall Street analysts recently?

What analysts cover Colgate-Palmolive?

Do Wall Street analysts like Colgate-Palmolive more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Colgate-Palmolive
Bull Case

Colgate-Palmolive
Bear Case